Skip to main content
. 2018 Jan 16;26:e20160531. doi: 10.1590/1678-7757-2016-0531

Figure 6. RUNX-2 immunostaining at 14 days for the experimental groups (CG: light; AG: moderate; BCG: moderate) and at 28 days (CG: light; AG: moderate; BCG: light). Immunolabeling indicated by red arrows.

Figure 6